Search results
Moderna, Merck say vaccine improved survival in patients with deadly skin cancer
NBC New York· 1 day agoModerna and Merck said their experimental vaccine in combination with the therapy Keytruda improved survival and showed durable efficacy in a midstage study in patients with ...
Jazz Pharmaceuticals Presents Overall Survival and Longer Follow-Up Data from HERIZON-BTC-01 Trial...
KOLR - KSFX Ozarks· 3 days agoJazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced long-term follow-up results, including the first-ever overall survival (OS) findings, from the Phase 2b HERIZON-BTC ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoPfizer also recently said its new drug, Adcetris, improved overall survival, progression-free ...
Gena McCarthy’s UNConventional Entertainment Signs With Buchwald
Deadline via Yahoo News· 20 hours agoEXCLUSIVE: Gena McCarthy and her UNConventional Entertainment banner has new representation. The ...
The Sustained, Slow Declining, Blood Concentration Profile of NV-387 Enables Infrequent Dosing for...
Morningstar· 5 hours agoThe Company has found that its lead nanoviricide broad-spectrum antiviral drug candidate NV-387, when given as a slow bolus intravenous infusion, resulted in a relatively ...
Bristol’s $250,000 pill slows lung cancer growth by 7 weeks
San Francisco Chronicle· 1 day agoA Bristol Myers Squibb Co. lung cancer treatment delayed tumor growth by less than seven weeks in a closely watched clinical trial, a disappointing result after the company
Innovent Announces Data from Pivotal Phase 2 TRUST-I Study of Taletrectinib(ROS1 Inhibitor) are...
Tehachapi News· 3 days agoInnovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Cruising Kitchens hit rock bottom, owner says, but not giving up
San Antonio Express-News· 1 day agoThe San Antonio builder of mobile kitchens already had an impressive roster of clients, including...
Gilead's Trodelvy fails to meet main goal in late-stage cancer study
Reuters via AOL· 5 days agoShares of Gilead fell 3.3% in extended trade after the company said the drug did not meet the main...
U.S. FDA ACKNOWLEDGES ASTELLAS' RESUBMISSION OF BIOLOGICS LICENSE APPLICATION FOR ZOLBETUXIMAB AND...
The Pendulum· 5 days ago(TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that the U.S. Food and Drug Administration (FDA) has acknowledged the company' ...